Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • The Cancer Index: Why investing in oncology biotechs is more science than art
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • The Cancer Index: Why investing in oncology biotechs is more science than art
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • The Cancer Index: Why investing in oncology biotechs is more science than art
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • The Cancer Index: Why investing in oncology biotechs is more science than art
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • The Cancer Index: Why investing in oncology biotechs is more science than art
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    Actinogen’s Phase 2a clinical trial for depression treatment fails to meet primary endpoint, shares tank
    • News

  • Holista Colltech banks on new partners to turn fortunes as food sales struggle
    Holista Colltech banks on new partners to turn fortunes as food sales struggle
    • News

  • Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    Zelira Therapeutics nears clinical trial stage for Autism drug following positive FDA feedback
    • News

  • Ardent Leisure freefalls 86%, now shuts doors to all theme parks and venues
    • News

    Ardent Leisure freefalls 86%, now shuts doors to all theme parks and venues

    It will be school holidays like none before with the coronavirus national emergency prompting Ardent Leisure (ASX: ALG) to shut their theme parks which include Dreamworld and Whitewater World.  The decision comes after Ardent had endured significantly difficult trading conditions prior to the global outbreak of COVID-19 following the death of four patrons in 2016

    Read More
    Public
  • After 3 years of development, Janison launches higher education assessment platform
    • News

    After 3 years of development, Janison launches higher education assessment platform

    University students in Singapore will soon be completing exam assessments online with Australian tech company Janison Education (ASX: JAN) having commissioned its online testing platform for the Institute of Technical Education (ITE).  The project was initially conceived in August 2016 when Janison partnered with S&I Systems and were awarded the contract by the Singapore ITE

    Read More
    Public
  • FDA grants Oncosil ‘Breakthrough Device’ status in fight against pancreatic cancer
    • News

    FDA grants Oncosil ‘Breakthrough Device’ status in fight against pancreatic cancer

    Accelerating the fight against pancreatic cancer, the United States Food and Drug Administration (FDA) is set to expedite an FDA application from medtech company OncoSil Medical (ASX: OSL) for their pancreatic treatment device.  The OncoSil(™) device has been granted Breakthrough Device Program (BDP) designation which is only granted to medical devices that may provide effective

    Read More
    Public
  • Tinybeans signs 10 partners in two weeks, including Amazon and Apple
    • News

    Tinybeans signs 10 partners in two weeks, including Amazon and Apple

    Despite the significant overall market downturn over the past fortnight, parenting tech company Tinybeans Group (ASX: TNY) has secured a handsome bundle of brand partners keen to use Tinybeans’ platforms to penetrate the lucrative parent and children markets.  The brand partners include Tier 1 partners Amazon, Apple, Kraft and National Geographic Kids as well as

    Read More
    Public
  • Murray River Organics Secures $15m Supermarket Supply Contract
    • News

    Murray River Organics Secures $15m Supermarket Supply Contract

    As Australian supermarket shelves are stripped bare from the hysteria of coronavirus panic buying, agriculture company Murray River Organics (ASX: MRG) will do their bit to meet demand, having secured a new deal worth $15 million.  The 2-year deal is a key milestone for Murray River Organics which has endured a torrid few years where

    Read More
    Public
  • Sezzle implements mandatory work-from-home policy, others to follow?
    • News

    Sezzle implements mandatory work-from-home policy, others to follow?

    Buy-Now-Pay-Later provider Sezzle (ASX: SZL) has taken proactive measures to prevent the spread of coronavirus amongst its employees by implementing a mandatory work-from-home policy across its global offices.  To be implemented immediately, the company has all the necessary technology in place to perform key work functions via cloud computing without any business interruptions to its

    Read More
    Public
  • Family Zone poised with homeschooling tech if U.S sees mass schools shutdown
    • News

    Family Zone poised with homeschooling tech if U.S sees mass schools shutdown

    Education tech company Family Zone (ASX: FZO) is well prepared in the United States in the event there is a mass shutdown of schools to prevent the spread of coronavirus which has already seen cancellations of mass gathering across various States.  Offering technology which supports and protects children through their digital journey, Family Zone’s software

    Read More
    Public
  • RooLife signed for AI marketing of skincare products to Chinese customers
    • News

    RooLife signed for AI marketing of skincare products to Chinese customers

    Artificial intelligence and marketing company RooLife Group (ASX: RLG) has been selected as the eCommerce marketer for skincare brand Nuria Beauty with an explicit mandate to target customers in China’s $33 billion skincare market.  The 2-year contract awarded by Small World Brands, the beauty and wellness company which produced the Nuria Beauty brand, is expected

    Read More
    Public
  • Dragontail extends AI-driven pizzas to Belgium via 100 Pizza Hut stores
    • News

    Dragontail extends AI-driven pizzas to Belgium via 100 Pizza Hut stores

    Progressive tech company Dragontail Systems (ASX: DTS) has continued its penetration of the fast food industry with 100 Pizza Hut stores in Belgium to adopt their Algo Platform which has already been adopted by global chains around the world.  The first-of-a-kind Algo Platform can be installed by fast food operators where a series of cameras,

    Read More
    Public
  • Another US State secured, Pointsbet approved for sportsbook launch in Indiana
    • News

    Another US State secured, Pointsbet approved for sportsbook launch in Indiana

    Wagering company PointsBet Holdings (ASX: PBH) has continued its national penetration of the American sports betting market having today announced they have secured approval to launch operations in the State of Indiana.  In the 17th largest State by population, regulatory approval from the Indiana Gaming Commission gives Pointsbet its third digital sportsbook operating in the

    Read More
    Public
  • «
  • ‹
  • 296
  • 297
  • 298
  • 299
  • 300
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.